Vanguard Group Inc Beyond Air, Inc. Transaction History

Vanguard Group Inc

$4.96 Trillion
Q1 2024

A detailed history of Vanguard Group Inc transactions in Beyond Air, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,399,298 shares of XAIR stock, worth $755,620. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,399,298

Previous 1,333,074 4.97%

Holding current value

$755,620

Previous $2.61 Million 6.81%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$1.3 - $2.15 $86,091 - $142,381	66,224 Added 4.97%	1,399,298 $2.43 Million
Q4 2023 Feb 14, 2024	BUY	$1.4 - $2.46 $21,389 - $37,583	15,278 Added 1.16%	1,333,074 $2.61 Million
Q3 2023 Nov 14, 2023	BUY	$2.31 - $4.18 $24,756 - $44,797	10,717 Added 0.82%	1,317,796 $3.04 Million
Q2 2023 Aug 14, 2023	BUY	$4.26 - $6.92 $538,540 - $874,812	126,418 Added 10.71%	1,307,079 $5.57 Million
Q1 2023 May 15, 2023	BUY	$5.65 - $7.56 $273,307 - $365,699	48,373 Added 4.27%	1,180,661 $7.97 Million

Q4 2022 Feb 10, 2023	BUY	$5.47 - $6.59 $2,871 - $3,459	525 Added 0.05%	1,132,288 $7.35 Million
Q3 2022 Nov 14, 2022	BUY	$7.42 - $11.39 $71,358 - $109,537	9,617 Added 0.86%	1,131,763 $8.42 Million
Q2 2022 Aug 12, 2022	BUY	$4.96 - $7.83 $987,521 - $1.56 Million	199,097 Added 21.57%	1,122,146 $7.51 Million
Q1 2022 May 13, 2022	BUY	$6.33 - $9.53 $94,563 - $142,368	14,939 Added 1.65%	923,049 $6.17 Million
Q4 2021 Feb 14, 2022	BUY	$8.44 - $15.61 $1.28 Million - $2.36 Million	151,369 Added 20.0%	908,110 $8.57 Million
Q3 2021 Nov 12, 2021	BUY	$5.9 - $12.54 $32,414 - $68,894	5,494 Added 0.73%	756,741 $8.41 Million
Q2 2021 Aug 13, 2021	BUY	$4.72 - $7.15 $3.55 Million - $5.37 Million	751,247 New	751,247 $4.87 Million

Others Institutions Holding XAIR

# of Institutions

Shares Held

15.8M

Call Options Held

48.7K

Put Options Held

27.2K

View Full List

About Beyond Air, Inc.

Ticker XAIR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 29,888,000
Market Cap $16.1M
Description
Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment ...

More about XAIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Beyond Air, Inc. Transaction History